Drug Shortage Report for APO-GUANFACINE XR
Report ID | 164378 |
Drug Identification Number | 02523728 |
Brand name | APO-GUANFACINE XR |
Common or Proper name | GUANFACINE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | GUANFACINE |
Strength(s) | 1MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | C02AC |
ATC description | ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-07-07 |
Estimated end date | 2022-08-19 |
Actual end date | 2022-08-11 |
Shortage status | Resolved |
Updated date | 2022-08-12 |
Company comments | 30 BTL is available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2022-08-12 | French | Compare |
v9 | 2022-08-12 | English | Compare |
v8 | 2022-08-12 | English | Compare |
v7 | 2022-08-05 | French | Compare |
v6 | 2022-08-05 | English | Compare |
v5 | 2022-07-22 | French | Compare |
v4 | 2022-07-22 | English | Compare |
v3 | 2022-07-11 | French | Compare |
v2 | 2022-07-11 | English | Compare |
v1 | 2022-07-11 | English | Compare |
Showing 1 to 10 of 10